Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Lateral Epicondylitis, (Tennis Elbow)

In brief

The objective of this study is to determine the safety and efficacy of a dexamethasone iontophoretic transdermal patch for the treatment of pain associated with lateral epicondylitis (tennis elbow).

Key facts

Study ID

NCT00794976

Run by

Travanti Pharma Inc.

People needed

216

Starts

2008-10-01

Expected to finish

2009-05-01

Last updated by the study team

2015-05-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with onset of lateral epicondylitis symptoms no more than 12 weeks prior to study entry
• Female patients of childbearing potential must agree to use a medically accepted form of birth control.

You may not qualify if…

• Subjects with other medical conditions/injuries of the elbow that would account for pain in the area
• Subjects who would require continuation of current pain medications during treatment
• Must not have received a prior corticosteroid injection for lateral epicondylitis in the affected arm

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — San Diego, California, United States
• Study site — Steamboat Springs, Colorado, United States
• Study site — Tampa, Florida, United States
• Study site — Oklahoma City, Oklahoma, United States
• Study site — Columbia, South Carolina, United States
• Study site — Dallas, Texas, United States
• Study site — Arlington, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.